New Strong Sell Stocks for Oct. 15th

Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:

Adherex Technologies FENC is a clinical-stage biotechnology company which is focused on the development of Sodium Thiosulfate for the prevention of ototoxicity from cisplatin in pediatric patients. The Zacks Consensus Estimate for its current year earnings has been revised almost 55.6 downward over the last 60 days.

Alibaba BABA is one of the leading e-commerce giants in China. The Zacks Consensus Estimate for its current year earnings has been revised almost 16.8% downward over the last 60 days.

Alico ALCO is involved in various operations and activities including citrus fruit production, cattle ranching, sugarcane and sod production, and forestry. The Zacks Consensus Estimate for its current year earnings has been revised 5.8% downward over the last 60 days.

View the entire Zacks Rank #5 List.

Zacks' Research Chief Names "Stock Most Likely to Double"

Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.

This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.

Free: See Our Top Stock And 4 Runners Up

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Alico, Inc. (ALCO) : Free Stock Analysis Report

Alibaba Group Holding Limited (BABA) : Free Stock Analysis Report

Adherex Technologies Inc. (FENC) : Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

More Related Articles

Info icon

This data feed is not available at this time.

Data is currently not available

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.